Vancomycin Hydrochloride Injection, Powder, Lyophilized, For Solution
Product Images NDC 0409-3515

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Vancomycin Hydrochloride (NDC 0409-3515). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Vancomycin 02)

Chemical structure of Vancomycin Hydrochloride showing its detailed molecular composition including rings, bonds, and functional groups, consistent with the active ingredient in the injection powder formulation. The diagram includes chlorine atoms, hydroxyl groups, amides, and other molecular features characteristic of Vancomycin.*

FDA Label Image

Logo (Vancomycin 03)

FDA Label Image

Principal Display Panel (750 mg Vial Label)

Label for Vancomycin Hydrochloride for Injection, USP, sterile powder for intravenous use. The label specifies an equivalent strength of 750 mg Vancomycin, with a warning that it must be further diluted before use. It includes storage instructions, dilution directions, and manufacturer Hospira, Inc. It also displays the NDC 0409-6531-12, lot, and expiration date placeholders.*

FDA Label Image

Principal Display Panel (750 mg Vial Tray)

Packaging label for Vancomycin Hydrochloride for Injection, USP sterile powder in a fliptap vial. The label states the product contains 750 mg equivalent of Vancomycin, for intravenous use, with instructions indicating it must be further diluted before use. The labeler is Hospira, Inc., and the label includes storage and reconstitution information, batch details, and a barcode.*

FDA Label Image

Principal Display Panel (1 g Vial Label)

Label for Vancomycin Hydrochloride for Injection, USP sterile powder, lyophilized, for intravenous use. The label states it contains the equivalent of 1 g Vancomycin, requires further dilution before use, and is distributed by Hospira, Inc. Usage instructions include dilution with sterile water and refrigeration after dilution.*

FDA Label Image

Principal Display Panel (1 g Vial Tray)

Packaging label for Vancomycin Hydrochloride for Injection, USP, 1 g strength. The label indicates it is a sterile powder in a fliptop vial for intravenous use, distributed by Hospira, Inc. Warnings state the product must be further diluted before use. The label includes lot, expiration, and serial number placeholders, along with storage and preparation instructions.*

FDA Label Image

Principal Display Panel (1 g Vial Carton)

Vancomycin Hydrochloride for Injection, USP sterile powder in a fliptop vial, equivalent to 1 g vancomycin per vial. The label indicates it is for intravenous use and must be further diluted before use. Distributed by Hospira, Inc. with manufacturing in Italy. Contains warnings and storage information along with the Hospira logo.*

FDA Label Image

Principal Display Panel (500 mg Vial Label)

Vancomycin Hydrochloride injection powder, lyophilized, for intravenous use, labeled as equivalent to 500 mg Vancomycin. The label notes the product is distributed by Hospira, Inc. and includes dosing instructions, storage conditions (refrigerate after dilution, store at 20 to 25°C prior to reconstitution), and a warning to dilute further before use as per package insert. The label also includes an NDC, barcode, and placeholders for lot and expiration data.*

FDA Label Image

Principal Display Panel (500 mg Vial Tray)

Packaging label for Vancomycin Hydrochloride for Injection, USP sterile powder by Hospira, Inc. The label indicates a strength equivalent to 500 mg Vancomycin per vial. It is for intravenous use and must be further diluted before use. The label includes storage instructions, dosage information, and NDC 0409-4332-01 on the vial label.*

FDA Label Image

Principal Display Panel (1.5 g Vial Label)

Vancomycin Hydrochloride for Injection, USP sterile powder label for intravenous use. The label states the product equivalent to 1.5 g Vancomycin and emphasizes dilution instructions. Distributed by Hospira, Inc., Lake Forest, IL. The label includes dosing, storage, and reconstitution information along with NDC 0409-3515-11.*

FDA Label Image

Principal Display Panel (1.5 g Vial Tray)

Label for Vancomycin Hydrochloride for Injection, USP sterile powder, equivalent to 1.5 g Vancomycin, for intravenous use. The label includes the brand name Vancomycin Hydrochloride, usage instructions indicating it must be further diluted before use, and distributor Hospira, Inc. The packaging notes storage conditions, reconstitution details, and a lot number section with expiration and serial information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.